Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Front Oncol · 2021 · PMC8167065 · PMID 34084749

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The reduced soluble mediator levels in treated MPN patients suggest that drug treatment influenced the production of many soluble mediators, although most of the comparisons did not reach statistical significance—except for G-CSF levels in PV patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.